All News about Bristol-Myers Squibb
Absence of Black Box Warning For Bristol Myers' Schizophrenia Treatment Could Enhance Alzheimer's Psychosis Potential
September 27, 2024
Via Benzinga
Exposures
Product Safety
What Analysts Are Saying About Bristol-Myers Squibb Stock
September 16, 2024
Via Benzinga
14 Stocks Gain Momentum As August Inflation Comes In Below Expectations
September 27, 2024
Via Benzinga
Topics
Economy
Exposures
Interest Rates
FDA Casts Doubt On Use Of Merck, Bristol Myers' PD-1 Cancer Drugs For Certain Type Of Gastric Cancer Patients
September 25, 2024
Via Benzinga
Exposures
Product Safety
10 Health Care Stocks With Whale Alerts In Today's Session
September 23, 2024
Via Benzinga
Bristol-Myers Acquired Drug KarXT Poised For FDA Approval As First New Type Of Schizophrenia Treatment In 70 Years
September 20, 2024
Via Benzinga
Exposures
Product Safety
Bristol Myers Squibb to Report Results for Third Quarter 2024 on October 31, 2024
September 12, 2024
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Squibb Announces Dividend
September 10, 2024
From Bristol Myers Squibb
Via Business Wire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Business Insurance is a singular, authoritative news and information source for executives focused upon risk management, risk transfer and risk financing.
Never miss important news. Subscribe to our newsletter.
Register for free